Tatsuo Fukushima

Takatsuki, 5698686, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Learning curves of 13 surgeons for robot-assisted radical prostatectomy in a single institution: role of early case density.

Learning curves of 13 surgeons for robot-assisted radical prostatectomy in a single institution: role of early case density.

Journal: Journal of robotic surgery

Published: February 08, 2026

A Two-Factor Bedside Prognostic Score Integrating Eastern Cooperative Oncology Group (ECOG) Performance Status and Aggressive Metastatic Burden in Metastatic Hormone-Sensitive Prostate Cancer.

A Two-Factor Bedside Prognostic Score Integrating Eastern Cooperative Oncology Group (ECOG) Performance Status and Aggressive Metastatic Burden in Metastatic Hormone-Sensitive Prostate Cancer.

Journal: The Prostate

Published: February 03, 2026

A ferroptosis-suppressive state drives resistance to bladder-preserving chemoradiotherapy in muscle-invasive bladder cancer.

A ferroptosis-suppressive state drives resistance to bladder-preserving chemoradiotherapy in muscle-invasive bladder cancer.

Journal: Signal transduction and targeted therapy

Published: January 30, 2026

Hypoxia-Induced MicroRNAs Confer Survival Advantage in Bladder Cancer by Fine-Tuning Oncogenic Pathways.

Hypoxia-Induced MicroRNAs Confer Survival Advantage in Bladder Cancer by Fine-Tuning Oncogenic Pathways.

Journal: Oncology

Published: December 21, 2025

Penile involvement associated with renal pelvic squamous cell carcinoma: a case report and mechanistic considerations.

Penile involvement associated with renal pelvic squamous cell carcinoma: a case report and mechanistic considerations.

Journal: Frontiers in oncology

Published: December 09, 2025

The Prognostic Significance of Radiographic Progression Without PSA Progression in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line ARPI Therapy.

The Prognostic Significance of Radiographic Progression Without PSA Progression in Patients With Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line ARPI Therapy.

Journal: The Prostate

Published: December 01, 2025

Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosis.

Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosis.

Journal: BJU international

Published: November 13, 2025

Clinical benefits of androgen receptor signaling inhibitors in patients with metastatic hormone-sensitive prostate cancer: real-world data from a multi-center study.

Clinical benefits of androgen receptor signaling inhibitors in patients with metastatic hormone-sensitive prostate cancer: real-world data from a multi-center study.

Journal: Japanese journal of clinical oncology

Published: March 26, 2025

Deciphering RCC immunotherapy outcomes: insights from a Japanese multi-institutional study on the CANLPH score's impact.

Deciphering RCC immunotherapy outcomes: insights from a Japanese multi-institutional study on the CANLPH score's impact.

Journal: World journal of urology

Published: December 30, 2024

Association of body mass index and tumor response in metastatic urothelial carcinoma treated with enfortumab vedotin: data from the ULTRA-Japan consortium.

Association of body mass index and tumor response in metastatic urothelial carcinoma treated with enfortumab vedotin: data from the ULTRA-Japan consortium.

Journal: International journal of clinical oncology

Published: November 10, 2024

Clinical significance of primary tumor progression in metastatic hormone-sensitive prostate cancer.

Clinical significance of primary tumor progression in metastatic hormone-sensitive prostate cancer.

Journal: Prostate international

Published: October 15, 2024

Characterization of PSA dynamics and oncological outcomes in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors.

Characterization of PSA dynamics and oncological outcomes in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors.

Journal: International journal of clinical oncology

Published: September 18, 2024

Showing 1-12 of 24

Last Updated: 09/26/2026